Skip to main content
. 2022 Mar 24;27(8):621–e617. doi: 10.1093/oncolo/oyac003
Disease Colorectal cancer
Stage of disease/treatment Neo-adjuvant
Prior therapy None
Type of study Phase I, 3 + 3
Primary endpoint Maximum tolerated dose
Investigator’s Analysis Active but results overtaken by other developments